English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 116 | Tables: 108 | Medical Devices & Consumables
The global Multileaf Collimators (MLCs) for Radiation Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Multileaf Collimators (MLCs) for Radiation Therapy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A multileaf collimator (MLC) is a Collimator or beam-limiting device that is made of individual "leaves" of a high atomic numbered material, usually tungsten, that can move independently in and out of the path of a radiotherapy beam in order to shape it and vary its intensity.
MLCs are used in external beam radiotherapy to provide conformal shaping of beams. Specifically, conformal radiotherapy and Intensity Modulated Radiation Therapy (IMRT) can be delivered using MLCs.
The North American market for Multileaf Collimators (MLCs) for Radiation Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Multileaf Collimators (MLCs) for Radiation Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy include LinaTech, ViewRay, 3D One, LAP GmbH, Huiheng Group, Shinva Medical Instrument, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Multileaf Collimators (MLCs) for Radiation Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Multileaf Collimators (MLCs) for Radiation Therapy. The Multileaf Collimators (MLCs) for Radiation Therapy market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Multileaf Collimators (MLCs) for Radiation Therapy market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Multileaf Collimators (MLCs) for Radiation Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
LinaTech
ViewRay
3D One
LAP GmbH
Huiheng Group
Shinva Medical Instrument
Segment by Type
<110 Leaves
110-120 Leaves
>120 Leaves
by Application
Hospital
Radiology Center
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Multileaf Collimators (MLCs) for Radiation Therapy manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Multileaf Collimators (MLCs) for Radiation Therapy sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Multileaf Collimators (MLCs) for Radiation Therapy Market Overview
1.1 Product Definition
1.2 Multileaf Collimators (MLCs) for Radiation Therapy by Type
1.2.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Type: 2025 vs 2032
1.2.2 <110 Leaves
1.2.3 110-120 Leaves
1.2.4 >120 Leaves
1.3 Multileaf Collimators (MLCs) for Radiation Therapy by Application
1.3.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Radiology Center
1.3.4 Others
1.4 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Size Estimates and Forecasts
1.4.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue 2021–2032
1.4.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales 2021–2032
1.4.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Multileaf Collimators (MLCs) for Radiation Therapy Market Competition by Manufacturers
2.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Manufacturers (2021–2026)
2.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Multileaf Collimators (MLCs) for Radiation Therapy, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Product Types and Applications
2.7 Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Date of Entry into the Industry
2.8 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Competitive Situation and Trends
2.8.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Multileaf Collimators (MLCs) for Radiation Therapy Players Market Share by Revenue
2.8.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Scenario by Region
3.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region: 2021–2032
3.2.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region: 2021–2026
3.2.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region: 2027–2032
3.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region: 2021–2032
3.3.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region: 2021–2026
3.3.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region: 2027–2032
3.4 North America Multileaf Collimators (MLCs) for Radiation Therapy Market Facts & Figures by Country
3.4.1 North America Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (2021–2032)
3.4.3 North America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multileaf Collimators (MLCs) for Radiation Therapy Market Facts & Figures by Country
3.5.1 Europe Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (2021–2032)
3.5.3 Europe Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region (2021–2032)
3.6.3 Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multileaf Collimators (MLCs) for Radiation Therapy Market Facts & Figures by Country
3.7.1 Latin America Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (2021–2032)
3.7.3 Latin America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (2021–2032)
3.8.3 Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Type (2021–2032)
4.1.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Type (2021–2026)
4.1.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Type (2027–2032)
4.1.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Type (2021–2032)
4.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Type (2021–2032)
4.2.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Type (2021–2026)
4.2.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Type (2027–2032)
4.2.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Type (2021–2032)
4.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Price by Type (2021–2032)
5 Segment by Application
5.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Application (2021–2032)
5.1.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Application (2021–2026)
5.1.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Application (2027–2032)
5.1.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Application (2021–2032)
5.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Application (2021–2032)
5.2.1 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Application (2021–2026)
5.2.2 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Application (2027–2032)
5.2.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Application (2021–2032)
5.3 Global Multileaf Collimators (MLCs) for Radiation Therapy Price by Application (2021–2032)
6 Key Companies Profiled
6.1 LinaTech
6.1.1 LinaTech Company Information
6.1.2 LinaTech Description and Business Overview
6.1.3 LinaTech Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 LinaTech Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.1.5 LinaTech Recent Developments/Updates
6.2 ViewRay
6.2.1 ViewRay Company Information
6.2.2 ViewRay Description and Business Overview
6.2.3 ViewRay Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ViewRay Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.2.5 ViewRay Recent Developments/Updates
6.3 3D One
6.3.1 3D One Company Information
6.3.2 3D One Description and Business Overview
6.3.3 3D One Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 3D One Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.3.5 3D One Recent Developments/Updates
6.4 LAP GmbH
6.4.1 LAP GmbH Company Information
6.4.2 LAP GmbH Description and Business Overview
6.4.3 LAP GmbH Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 LAP GmbH Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.4.5 LAP GmbH Recent Developments/Updates
6.5 Huiheng Group
6.5.1 Huiheng Group Company Information
6.5.2 Huiheng Group Description and Business Overview
6.5.3 Huiheng Group Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huiheng Group Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.5.5 Huiheng Group Recent Developments/Updates
6.6 Shinva Medical Instrument
6.6.1 Shinva Medical Instrument Company Information
6.6.2 Shinva Medical Instrument Description and Business Overview
6.6.3 Shinva Medical Instrument Multileaf Collimators (MLCs) for Radiation Therapy Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shinva Medical Instrument Multileaf Collimators (MLCs) for Radiation Therapy Product Portfolio
6.6.5 Shinva Medical Instrument Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multileaf Collimators (MLCs) for Radiation Therapy Industry Chain Analysis
7.2 Multileaf Collimators (MLCs) for Radiation Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multileaf Collimators (MLCs) for Radiation Therapy Production Mode & Process Analysis
7.4 Multileaf Collimators (MLCs) for Radiation Therapy Sales and Marketing
7.4.1 Multileaf Collimators (MLCs) for Radiation Therapy Sales Channels
7.4.2 Multileaf Collimators (MLCs) for Radiation Therapy Distributors
7.5 Multileaf Collimators (MLCs) for Radiation Therapy Customer Analysis
8 Multileaf Collimators (MLCs) for Radiation Therapy Market Dynamics
8.1 Multileaf Collimators (MLCs) for Radiation Therapy Industry Trends
8.2 Multileaf Collimators (MLCs) for Radiation Therapy Market Drivers
8.3 Multileaf Collimators (MLCs) for Radiation Therapy Market Challenges
8.4 Multileaf Collimators (MLCs) for Radiation Therapy Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Competitive Situation by Manufacturers in 2025
Table 4. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Multileaf Collimators (MLCs) for Radiation Therapy Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Multileaf Collimators (MLCs) for Radiation Therapy, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Product Types and Applications
Table 12. Global Key Manufacturers of Multileaf Collimators (MLCs) for Radiation Therapy, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Multileaf Collimators (MLCs) for Radiation Therapy Companies by Tier (Tier 1, Tier 2, Tier 3), based on Multileaf Collimators (MLCs) for Radiation Therapy Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region (Units), 2021–2026
Table 18. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Region (2021–2026)
Table 19. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region (Units), 2027–2032
Table 20. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Region (2027–2032)
Table 21. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region (US$ Million), 2021–2026
Table 22. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Region (2021–2026)
Table 23. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region (US$ Million), 2027–2032
Table 24. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Region (2027–2032)
Table 25. North America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2021–2026
Table 27. North America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2027–2032
Table 28. North America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2021–2026
Table 29. North America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2021–2026
Table 32. Europe Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2027–2032
Table 33. Europe Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2021–2026
Table 42. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2027–2032
Table 43. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Revenue by Country (US$ Million), 2027–2032
Table 50. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units) by Type (2021–2026)
Table 51. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units) by Type (2027–2032)
Table 52. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Type (2021–2026)
Table 53. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Type (2027–2032)
Table 54. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Type (2021–2026)
Table 57. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Type (2027–2032)
Table 58. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Type (2021–2026)
Table 59. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Type (2027–2032)
Table 60. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units) by Application (2021–2026)
Table 61. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units) by Application (2027–2032)
Table 62. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Application (2021–2026)
Table 63. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Application (2027–2032)
Table 64. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Application (2021–2026)
Table 67. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Application (2027–2032)
Table 68. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Application (2021–2026)
Table 69. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Application (2027–2032)
Table 70. LinaTech Company Information
Table 71. LinaTech Description and Business Overview
Table 72. LinaTech Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. LinaTech Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 74. LinaTech Recent Developments/Updates
Table 75. ViewRay Company Information
Table 76. ViewRay Description and Business Overview
Table 77. ViewRay Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. ViewRay Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 79. ViewRay Recent Developments/Updates
Table 80. 3D One Company Information
Table 81. 3D One Description and Business Overview
Table 82. 3D One Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. 3D One Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 84. 3D One Recent Developments/Updates
Table 85. LAP GmbH Company Information
Table 86. LAP GmbH Description and Business Overview
Table 87. LAP GmbH Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. LAP GmbH Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 89. LAP GmbH Recent Developments/Updates
Table 90. Huiheng Group Company Information
Table 91. Huiheng Group Description and Business Overview
Table 92. Huiheng Group Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Huiheng Group Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 94. Huiheng Group Recent Developments/Updates
Table 95. Shinva Medical Instrument Company Information
Table 96. Shinva Medical Instrument Description and Business Overview
Table 97. Shinva Medical Instrument Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shinva Medical Instrument Multileaf Collimators (MLCs) for Radiation Therapy Product
Table 99. Shinva Medical Instrument Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Multileaf Collimators (MLCs) for Radiation Therapy Distributors List
Table 103. Multileaf Collimators (MLCs) for Radiation Therapy Customers List
Table 104. Multileaf Collimators (MLCs) for Radiation Therapy Market Trends
Table 105. Multileaf Collimators (MLCs) for Radiation Therapy Market Drivers
Table 106. Multileaf Collimators (MLCs) for Radiation Therapy Market Challenges
Table 107. Multileaf Collimators (MLCs) for Radiation Therapy Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Multileaf Collimators (MLCs) for Radiation Therapy
Figure 2. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Share by Type: 2025 & 2032
Figure 4. <110 Leaves Product Picture
Figure 5. 110-120 Leaves Product Picture
Figure 6. >120 Leaves Product Picture
Figure 7. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Radiology Center
Figure 11. Others
Figure 12. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Size (US$ Million), 2021–2032
Figure 14. Global Multileaf Collimators (MLCs) for Radiation Therapy Sales (Units), 2021–2032
Figure 15. Global Multileaf Collimators (MLCs) for Radiation Therapy Average Price (US$/Unit), 2021–2032
Figure 16. Multileaf Collimators (MLCs) for Radiation Therapy Report Years Considered
Figure 17. Multileaf Collimators (MLCs) for Radiation Therapy Sales Share by Manufacturers in 2025
Figure 18. Global Multileaf Collimators (MLCs) for Radiation Therapy Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Multileaf Collimators (MLCs) for Radiation Therapy Players: Market Share by Revenue in Multileaf Collimators (MLCs) for Radiation Therapy in 2025
Figure 20. Multileaf Collimators (MLCs) for Radiation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Multileaf Collimators (MLCs) for Radiation Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Country (2021–2032)
Figure 23. North America Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Country (2021–2032)
Figure 24. United States Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Country (2021–2032)
Figure 27. Europe Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Country (2021–2032)
Figure 28. Germany Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Region (2021–2032)
Figure 35. China Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Country (2021–2032)
Figure 43. Latin America Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Multileaf Collimators (MLCs) for Radiation Therapy Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Multileaf Collimators (MLCs) for Radiation Therapy Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Multileaf Collimators (MLCs) for Radiation Therapy by Type (2021–2032)
Figure 54. Global Revenue Market Share of Multileaf Collimators (MLCs) for Radiation Therapy by Type (2021–2032)
Figure 55. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Multileaf Collimators (MLCs) for Radiation Therapy by Application (2021–2032)
Figure 57. Global Revenue Market Share of Multileaf Collimators (MLCs) for Radiation Therapy by Application (2021–2032)
Figure 58. Global Multileaf Collimators (MLCs) for Radiation Therapy Price (US$/Unit) by Application (2021–2032)
Figure 59. Multileaf Collimators (MLCs) for Radiation Therapy Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
